Key result
This article provides an update on cardiovascular pharmacotherapy, specifically focusing on hyperkalemia associated with combined aldosterone and angiotensin blockade in heart failure.
This feature highlights the importance of pharmacists staying current with cardiovascular pharmacotherapy developments to impact patient care.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Patricia Howard (2006) conducted a review in Heart Failure. Combined Aldosterone and Angiotensin Blockade was evaluated on Hyperkalemia. This article provides an update on cardiovascular pharmacotherapy, specifically focusing on hyperkalemia associated with combined aldosterone and angiotensin blockade in heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: